Erik Roberson

Affiliations: 
2008- Neurology & Neurobiology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Neurodegenerative Disease
Website:
http://www.robersonlab.net
Google:
"Erik Roberson"
Mean distance: 13.2 (cluster 6)
 
SNBCP

Parents

Sign in to add mentor
J. David Sweatt grad student 1991-1997 Baylor College of Medicine
Bruce L. Miller post-doc 2003-2005 UCSF
Lennart Mucke research scientist 2003-2006 Gladstone Institute

Children

Sign in to add trainee
Samantha J Thompson research assistant 2015-2018 UAB
Rachael Vollmer research assistant 2018-2020 UAB
Jonathan R. Roth grad student 2017- UAB
Hunter Byron Dean grad student 2018- UAB
Shreya Natesh Kashyap grad student 2018- UAB
M. Natalie Davis grad student 2020- UAB
Ryan Tuckey grad student 2022- University of Alabama at Birmingham School of Medicine
Zhiyong Li grad student 2009-2014 UAB
Brian A. Warmus grad student 2010-2014 UAB
Alicia M. Hall grad student 2009-2015 UAB
J. Nicholas (Nick) Cochran grad student 2011-2015 UAB
Yuliya Voskobiynyk grad student 2015-2021 UAB
Mary Bullock Cooper grad student 2021-2026 UAB
Stephanie N Fox post-doc 2022- University of Alabama at Birmingham School of Medicine
Anthony J. Filiano post-doc 2009-2013 UAB
Travis Rush post-doc 2014-2017 UAB
Andrew E. Arrant post-doc 2013-2019 UAB

Collaborators

Sign in to add collaborator
Yuhua Song collaborator 2018- UAB (Computational Biology Tree)
David Luke Fischer collaborator 2020-2022 UAB
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Roth JR, Rush T, Thompson SJ, et al. (2023) Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitability. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 21: e00291
Rajabli F, Benchek P, Tosto G, et al. (2023) Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies and nominates ancestry-specific loci , , and as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium. Medrxiv : the Preprint Server For Health Sciences
Zhang L, Flagan TM, Häkkinen S, et al. (2023) Network connectivity alterations across the MAPT mutation clinical spectrum. Annals of Neurology
Kurnellas M, Mitra A, Schwabe T, et al. (2023) Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia. Journal of Translational Medicine. 21: 387
Wright CA, Taylor JW, Cochran M, et al. (2023) Contributions of rare and common variation to early-onset and atypical dementia risk. Cold Spring Harbor Molecular Case Studies
Wright CA, Taylor JW, Cochran M, et al. (2023) Contributions of rare and common variation to early-onset and atypical dementia risk. Medrxiv : the Preprint Server For Health Sciences
Kashyap SN, Boyle NR, Roberson ED. (2023) Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics
Staffaroni AM, Quintana M, Wendelberger B, et al. (2022) Temporal order of clinical and biomarker changes in familial frontotemporal dementia. Nature Medicine
Gannon M, Wang B, Stringfellow SA, et al. (2022) 14-3-3θ does not protect against behavioral or pathological deficits in Alzheimer's disease mouse models. Eneuro
Shao E, Chang CW, Li Z, et al. (2022) TAU ablation in excitatory neurons and postnatal TAU knockdown reduce epilepsy, SUDEP, and autism behaviors in a Dravet syndrome model. Science Translational Medicine. 14: eabm5527
See more...